NASDAQ:PCSA

Processa Pharmaceuticals Stock Insider Trading

etoro logo Buy PCSA
*Your capital is at risk
$2.80
-0.120 (-4.11%)
At Close: Jun 03, 2026

Processa Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 8.93M and sold 0 PCSA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 8.93M shares
Sell 0 shares
100% Buy Activity
Negligible or No Correlation
Buy Signal High Confidence
May 29, 2026

Analysis Breakdown:

  • Strongly supported by a very high Insider Power Score of 100.
  • Confidence increased due to high data reliability score of 100.
  • Supported by overwhelming buy-side pressure (100% buys).

Historical Insider Trades

Date Type Person Role Amount
May 29, 2026
Buy
Common Stock
P-Purchase
Lin Patrick
Chief Business - Strategy Off
Officer 1 582
Value: $4K
May 29, 2026
Buy
Common Stock
P-Purchase
Ng George K
Chief Executive Officer
CEO / President 2 129
Value: $5K
May 29, 2026
Buy
Common Stock
P-Purchase
Skibsted Russell
Chief Financial Officer
C-Suite Officer 2 292
Value: $6K
May 29, 2026
Buy
Common Stock
P-Purchase
Young David
Pres. Research & Development
Officer 1 786
Value: $5K
May 29, 2026
Buy
Common Stock
P-Purchase
Guy Wendy
Chief Administrative Officer
Officer 1 829
Value: $5K
May 15, 2026
Buy
Common Stock
P-Purchase
Skibsted Russell
Chief Financial Officer
C-Suite Officer 1 984
Value: $6K
May 15, 2026
Buy
Common Stock
P-Purchase
Guy Wendy
Chief Administrative Officer
Officer 1 583
Value: $5K
May 15, 2026
Buy
Common Stock
P-Purchase
Lin Patrick
Chief Business - Strategy Off
Officer 1 369
Value: $4K
May 15, 2026
Buy
Common Stock
P-Purchase
Young David
Pres. Research & Development
Officer 1 545
Value: $5K
May 15, 2026
Buy
Common Stock
P-Purchase
Ng George K
Chief Executive Officer
CEO / President 1 843
Value: $5K
Apr 30, 2026
Buy
Common Stock
P-Purchase
Bigora Sian
Chief Development Officer
Officer 1 971
Value: $5K
Apr 30, 2026
Buy
Common Stock
P-Purchase
Young David
Pres. Research & Development
Officer 1 706
Value: $5K
Apr 30, 2026
Buy
Common Stock
P-Purchase
Skibsted Russell
Chief Financial Officer
C-Suite Officer 2 190
Value: $6K
Apr 30, 2026
Buy
Common Stock
P-Purchase
Ng George K
Chief Executive Officer
CEO / President 2 034
Value: $5K
Apr 30, 2026
Buy
Common Stock
P-Purchase
Lin Patrick
Chief Business - Strategy Off
Officer 1 511
Value: $4K
Apr 30, 2026
Buy
Common Stock
P-Purchase
Guy Wendy
Chief Administrative Officer
Officer 1 748
Value: $5K
Apr 30, 2026
Buy
Common Stock
P-Purchase
Bigora Sian
Chief Development Officer
Officer 1 986
Value: $5K
Apr 15, 2026
Buy
Common Stock
P-Purchase
Ng George K
Chief Executive Officer
CEO / President 1 843
Value: $5K
Apr 15, 2026
Buy
Common Stock
P-Purchase
Guy Wendy
Chief Administrative Officer
Officer 1 583
Value: $5K
Apr 15, 2026
Buy
Common Stock
P-Purchase
Lin Patrick
Chief Business - Strategy Off
Officer 1 369
Value: $4K
Apr 15, 2026
Buy
Common Stock
P-Purchase
Ng George K
Chief Executive Officer
CEO / President 1 843
Value: $5K
Apr 15, 2026
Buy
Common Stock
P-Purchase
Young David
Pres. Research & Development
Officer 1 545
Value: $5K
Apr 15, 2026
Buy
Common Stock
P-Purchase
Bigora Sian
Chief Development Officer
Officer 1 799
Value: $5K
Apr 15, 2026
Buy
Common Stock
P-Purchase
Skibsted Russell
Chief Financial Officer
C-Suite Officer 1 984
Value: $6K
Mar 31, 2026
Buy
Common Stock
P-Purchase
Ng George K
Chief Executive Officer
CEO / President 2 136
Value: $5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT PROCESSA PHARMACEUTICALS INC.
Processa Pharmaceuticals
Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the treatment of ulcerative and non-ulcerative necrobiosis lipoidica, a chronic disfiguring condition. The company is also developing PCS12852, a novel selectiv...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE